Trump announces 100% tariff on generic drug imports from 2028

Trump announced a 100% tariff on generic drug imports starting in 2028 to boost domestic pharmaceutical manufacturing. This initiative significantly impacts India, where generic drugmakers operate on thin margins and face challenges absorbing these new costs. The plan aims to strengthen the domestic pharmaceutical industry by reducing reliance on foreign imports. Consequently, the pharmaceutical sector must navigate these financial pressures as the United States seeks to prioritize internal production over international generic drug sourcing.